Want to see AU:XRF full AI Analyst Report?
Top Page
XRF Scientific Limited
(Sydney:XRF)
Select Model
Select Model
Rating:67Neutral
Price Target:
AU$2.00
â–˛(16.96% Upside)
Action:Reiterated
Date:12/11/25
XRF Scientific Limited's overall stock score reflects strong financial performance with efficient operations and a solid balance sheet. However, mixed technical indicators and moderate valuation suggest limited growth potential without new catalysts. The absence of earnings call insights and corporate events further limits the score.
Positive Factors
Low Leverage / Strong Balance Sheet
A very low debt-to-equity ratio and strong equity base provide durable financial flexibility. This reduces refinancing risk during commodity or capex cycles, supports targeted investment or acquisitions, and underpins stable capital allocation and shareholder distributions over the next 2–6 months.
Negative Factors
Weakening Revenue Trend
A recent contraction in reported revenue growth signals potential demand softness or loss of market share. Over a 2–6 month horizon this can erode operating leverage, constrain reinvestment, and require either renewed sales initiatives or product entry to restore sustainable top-line momentum.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
A very low debt-to-equity ratio and strong equity base provide durable financial flexibility. This reduces refinancing risk during commodity or capex cycles, supports targeted investment or acquisitions, and underpins stable capital allocation and shareholder distributions over the next 2–6 months.
Read all positive factors
XRF Scientific Limited (XRF) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$261.76M
Dividend Yield2.46%
Average Volume (3M)240.16K
Price to Earnings (P/E)24.9
Beta (1Y)1.10
Revenue Growth3.02%
EPS Growth11.08%
CountryAU
Employees48
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)0.08
Shares Outstanding143,040,080
10 Day Avg. Volume163,831
30 Day Avg. Volume240,164
Financial Highlights & Ratios
PEG Ratio1.67
Price to Book (P/B)4.29
Price to Sales (P/S)4.34
P/FCF Ratio30.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)AU$71.85M
XRF Scientific Limited Business Overview & Revenue Model
Company Description
XRF Scientific Limited is a supplier to the scientific, analytical, construction materials, and mining sectors across Australia, Canada, and Europe. The company produces and sells precious metal items, specialized chemical compounds, and various i...
How the Company Makes Money
XRF makes money primarily by selling and distributing laboratory consumables and equipment used in sample preparation and materials analysis, with recurring revenue generated from repeat purchasing of consumables and replacement parts. Key revenue...
XRF Scientific Limited Financial Statement Overview
Summary
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.91M | 59.45M | 59.84M | 55.17M | 40.01M | 31.29M |
| Gross Profit | 30.13M | 28.79M | 26.27M | 22.00M | 16.46M | 12.89M |
| EBITDA | 17.66M | 15.63M | 15.32M | 13.22M | 9.44M | 8.05M |
| Net Income | 10.63M | 10.38M | 8.89M | 7.69M | 6.08M | 5.13M |
Balance Sheet | ||||||
| Total Assets | 70.03M | 72.79M | 68.23M | 65.55M | 55.56M | 48.37M |
| Cash, Cash Equivalents and Short-Term Investments | 12.07M | 12.23M | 12.05M | 10.40M | 6.65M | 5.26M |
| Total Debt | 3.23M | 4.41M | 3.38M | 4.31M | 3.51M | 1.44M |
| Total Liabilities | 8.67M | 12.62M | 12.69M | 15.97M | 12.21M | 9.27M |
| Stockholders Equity | 61.36M | 60.17M | 54.89M | 49.25M | 43.48M | 39.10M |
Cash Flow | ||||||
| Free Cash Flow | 10.17M | 8.39M | 6.45M | 7.63M | 2.63M | 3.86M |
| Operating Cash Flow | 12.10M | 10.14M | 8.09M | 8.42M | 3.15M | 4.51M |
| Investing Cash Flow | -1.77M | -2.21M | -1.64M | -782.43K | -1.11M | -652.62K |
| Financing Cash Flow | -6.40M | -7.75M | -4.80M | -3.88M | -648.95K | -2.24M |
XRF Scientific Limited Technical Analysis
Positive
1.71
Price Trends
1.77
Positive
1.78
Positive
1.88
Negative
Market Momentum
<0.01
Negative
62.58
Neutral
76.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRF, the sentiment is Positive. The current price of 1.71 is below the 20-day moving average (MA) of 1.72, below the 50-day MA of 1.77, and below the 200-day MA of 1.88, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 62.58 is Neutral, neither overbought nor oversold. The STOCH value of 76.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:XRF.
XRF Scientific Limited Peers Comparison
UnderperformOutperform
Sector (63)
AU:XRF
XRF Scientific Limited
1.83
-0.19
-9.41%
AU:IMD
Imdex Ltd
3.87
0.61
18.86%
XRF Scientific Limited Corporate Events
XRF Scientific Director Restructures Shareholdings via Off‑Market Transfer
Jun 23, 2026
XRF Scientific has reported a change in the shareholdings of director David Brown, reflecting an off‑market transfer between his direct holding and his interest via the Pandora Super (WA) Pty Ltd, as trustee for the Pandora Super Fund. Follo...
XRF Scientific Showcases Broad Role in Sample Preparation and Analysis Technology
Jun 8, 2026
XRF Scientific Limited highlights its role as a provider of specialised sample preparation and chemical analysis technology used across a broad range of mineral commodities and industrial materials. The company’s solutions support key analyt...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.